Tolerance Bio

Developer of thymus-based therapies for immune-mediated diseases to increase healthspan

placeChapel Hill, North Carolina, United States calendar_todayFounded 2023 language tolerancebio.com

Social engagement

Social engagement: 2.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Columbus Venture Partners.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%

Recent activity

9 Dec 2025
Event
Hanson Wade 6th Age-Related Disease Therapeutics Summit
17 Nov 2025
Event
Advanced Therapies, LLC USA 2025 Congress
8 Oct 2025
Recognition
Coming soon